Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Phosphoproteome of patient derived lung cancer cells

ABSTRACT: pSTY and pY phosphoproteome analysis of patient derived lung cancer cells, JFCR 28-03, 28-04 and 28-05.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Ryohei Katayama

PROVIDER: PXD028445 | JPOST Repository | Tue Feb 08 00:00:00 GMT 2022

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	170223_Kyo1st_Set1_Phos1.raw	Raw
	170223_Kyo1st_Set1_Phos2.raw	Raw
	170223_Kyo1st_Set1_Phos3.raw	Raw
	170223_Kyo1st_Set1_Phos4.raw	Raw
	170223_Kyo1st_Set1_Phos5.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

Phosphoproteome of lung cancer cells

Project description:pSTY and pY proteome data of lung cancer cells labeled by TMTpro reagent.

2021-01-26 | PXD023744 | JPOST Repository

Phosphoproteome of NSCLC patient–derived cells.

Project description:Phosphoproteome of anaplastic lymphoma kinase–positive non-small cell lung cancer (ALK+ NSCLC) patient–derived cells.

2024-11-19 | PXD050973 | JPOST Repository

Multi-omics profiling of non-small cell lung cancer patient-derived xenografts reveals proteome and phosphoproteome remodeling associated with patient outcome

Project description:131 patient-derived xenograft models were generated for non-small cell lung carcinoma and were profiled by analysis of gene copy number variation, whole exome sequence, methylome, transcriptome, proteome, and phospho(Tyr)-proteome. Proteome profiling resolved the known major histology subtypes and revealed 3 proteome subtypes (proteotypes) among adenocarcinoma and 2 in squamous cell carcinoma that were associated with distinct protein-phosphotyrosine signatures and patient survival. Proteomes of human tumor were discernible from murine stroma. Stromal proteomes were similar between histological subtypes, but two adenocarcinoma proteotypes had distinct stromal proteomes. Tumor and stromal proteotypes comprise signatures of targetable biological pathways suggesting that patient stratification by proteome profiling may be an actionable approach to precisely diagnose and treat cancer.

2021-11-24 | PXD016579 | Pride

Multi-omics profiling of non-small cell lung cancer patient-derived xenografts reveals proteome and phosphoproteome remodeling associated with patient outcome

Project description:131 patient-derived xenograft models were generated for non-small cell lung carcinoma and were profiled at the genome, transcriptome and proteome level by analysis of gene copy number variation, whole exome sequencing, DNA methylation, transcriptome, proteome and phospho(Tyr)-proteome. At the proteome level, the human tumor and murine stroma were discernible. Tumor proteome profiling resolved the known major histological subtypes and revealed 3 proteome subtypes (proteotypes) among adenocarcinoma and 2 in squamous cell carcinoma that were associated with distinct protein-phosphotyrosine signatures and patient survival. Stromal proteomes were similar between histological subtypes, but two adenocarcinoma proteotypes had distinct stromal proteomes. Proteotypes comprise tumor and stromal signatures of targetable biological pathways suggesting that patient stratification by proteome profiling may be an actionable approach to precisely diagnose and treat cancer.

2021-11-24 | PXD016674 | Pride

Modeling Lung Adenocarcinoma Metastases Using Patient-Derived Organoids

Project description:Modeling Lung Adenocarcinoma Metastases Using Patient-Derived Organoids

| PRJNA1157185 | ENA

Transcriptomic analysis of patient-derived resected lung NSCLC cells

Project description:Transcriptomic analysis of patient-derived resected lung NSCLC cells

| PRJNA941787 | ENA

Transcriptomic analysis of sotorasib-resistant patient-derived xenograft (PDX) lung tumor cells

Project description:To characterize sotorasib resistance in lung adenocarcinomas (LUAD), we implanted pieces derived from a patient-derived KRAS-G12C positive xenograft (PDX) lung tumor model in immunocompromised mice

2023-03-05 | GSE204753 | GEO

Single-cell RNA sequencing of lung adenocarcinoma patient-derived cells

Project description:To address how intratumoral heterogeneity affects anti-cancer drug responses, we profiled transcriptomes of single cancer cells originating from lung adenocarcinoma patient-derived xenograft (PDX) tumors.

2015-06-03 | GSE69405 | GEO

Patient-Derived Lung Cancer Organoid

Project description:Lung cancer shows substantial genetic and phenotypic heterogeneity across individuals, driving a need for personalized medicine. Here we report lung cancer organoids and normal bronchial organoids established from patients tissues comprising five histological subtypes of lung cancer and non-neoplastic bronchial mucosa as in vitro models representing individual patient. The lung cancer organoids recapitulate the tissue architecture of the primary lung tumours and maintain the genomic alterations of the original tumours during long-term expansion in vitro. The normal bronchial organoids maintain cellular components of normal bronchial mucosa. Lung cancer organoids respond to drugs based on their genomic alterations: a BRCA2 mutant organoid to olaparib, an EGFR mutant organoid to erlotinib, and an EGFR mutant/MET amplified organoid to crizotinib. Considering the short length of time from organoid establishment to drug testing, our newly developed model may prove useful for predicting patient-specific drug responses through in vitro patient-specific drug trials.

| EGAS00001003786 | EGA

Kunming Lung Cancer Patient Fecal

Project description:Kunming Lung Cancer Patient Fecal Targeted loci environmental

| PRJNA461632 | ENA